http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011101056-A4
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
filingDate | 2011-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e47434594fac08811ec8d554d0f81cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6431d1eb751bfe7983451a8763bf2b97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56672bb9941c3929e771662f2e0fc4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df45eb3939410e27d8f9377f2de37b9 |
publicationDate | 2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2011101056-A4 |
titleOfInvention | Injection paradigm for administration of botulinum toxins |
abstract | 18714 PCT (BOT) Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine. |
priorityDate | 2010-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.